Relay Therapeutics Inc

NASDAQ:RLAY  
29.18
+1.68 (+6.11%)
Earnings Announcements

Relay Therapeutics Reports Fourth Quarter And Full Year 2020 Financial Results And Operational Highlights

Published: 03/25/2021 20:22 GMT
Relay Therapeutics Inc (RLAY) - Relay Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights.
Relay Therapeutics Inc - Cash, Cash Equivalents and Marketable Securities Expected to Fund Operations Into 2024.
Relay Therapeutics Inc - Net Income Was $35.3 Million for Q4.
Revenue is expected to be $6.67 Million
Adjusted EPS is expected to be -$0.45

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.50

More details on our Analysts Page.